1776
|
Morris P, Chen C, Lin N, Moy B, Come S, Abbruzzi A, Patil S, Winer E, Norton L, Hudis C, Dang C. Dose-Dense (dd) Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Paclitaxel (P) with Trastuzumab (T) and Lapatinib (L) in Early Breast Cancer (EBC); Troponin I and C-Reactive Protein as Biomarkers of Cardiotoxicity. Cancer Res 2009. [DOI: 10.1158/0008-5472.sabcs-09-3088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
BackgroundThe early detection of cardiotoxicity and congestive heart failure (CHF) from anthracyclines and anti-HER2 agents is currently limited to measuring changes in left ventricular ejection fraction (LVEF) at arbitrary time points. This approach has limited sensitivity and specificity and has led to the investigation of putative biomarkers such as cardiac Troponin I (TnI), a highly specific marker of myocardial damage and C-reactive protein (CRP), a sensitive inflammatory marker. In a pre-planned analysis we investigated these as biomarkers of cardiotoxicity within a prospective study testing the feasibility of ddAC- followed by weekly P with T and L.Materials and MethodsPatients (pts) with HER2+ EBC enrolled at MSKCC and DF/HCC and received ddAC (A 60mg/m2 + C 600mg/m2) x 4 → weekly P (80mg/m2) x 12 + T + L (1000mg/day). T+L continued for a total of 1yr. At baseline pts had LVEF ≥50%. Pts with unstable angina, CHF, recent MI, uncontrolled arrhythmia, grade 3 QT prolongation were excluded. LVEF was assessed by MUGA scan at mths 0, 2, 6, 9 and 18. TnI and CRP were measured every 2 wks right before treatment (Rx) during ddAC-PTL, then at mths 6, 9 and 18. TnI was categorized as “undetectable” (< 0.06 ng/ml; MSKCC, <0.04 ng/ml; DF/HCC), “minimally elevated” (<0.31 ng/ml) and “elevated” (>0.31ng/ml). Elevated CRP was defined as (>0.8mg/dl; MSKCC, >0.3mg/dl; DF/HCC). Investigators were blinded to these results until pts completed 18mth follow-up (F/U).ResultsFrom Apr 07- Apr 08, 95 pts were enrolled; 39/95 (41%) withdrew due to PTL toxicities (incl. 3 with asymptomatic LVEF (aLVEF) declines and 3 with CHF). Final biomarker results were available in 84 pts (88%) and 11 pts (12%) continue on study. During Rx, minimal elevations in TnI occurred in 55 pts (65%). One pt had ↑TnI above normal range with AC#4; MUGA 1 wk later was unchanged (LVEF 75%), but she died from sepsis during subsequent Rx without evidence of CHF. Elevations in TnI occurred only during chemoRx and no pt had a ↑TnI during TL or at 18mth F/U. Of 55pts with elevated TnI, 25 (45%) had aLVEF declines (3 ↓ ≥16%, 10 ↓ 10-15%, 12 ↓ 5<10%). Of 29 pts with undetectable TnI, 7 (24%) had aLVEF declines (1 ↓ ≥16%, 4 ↓ 10-15%, 2↓ 5<10%). Elevations in CRP occurred in 61/84 (73%) pts during chemoRx but only in 22 (26%) during TL or at 18mth F/U. Three pts discontinued Rx for aLVEF ↓ at mths 4, 5 and 7 respectively; 2 (66%) had rises in CRP and 2 had minimal elevation in TnI. Three pts developed CHF at mths 3, 6, and 12 respectively, all had rises in CRP; 1 pt had a single ↑TnI of 0.08 ng/ml during chemoRx, and 2pts had no ↑TnIs.ConclusionsIn pts receiving ddAC-PTL fluctuations in TnI and CRP are common but do not persist after chemoRx (during TL). These biomarkers do not appear to predict for CHF. One possibility is that the timing of the drawing of these biomarkers (immediately preceding the specified treatment cycle and after Rx completion) may have been suboptimal. We plan to assess for potential biomarkers by assessing both immediately preceding and following therapy in a planned trial. Updated results will be presented.
Citation Information: Cancer Res 2009;69(24 Suppl):Abstract nr 3088.
Collapse
|
1777
|
Blay J, Lluch A, Gutierrez M, Martin M, Kozloff M, Prady C, Huang X, Verkh L, Chen C, Tassell V, Kern K, Verma S. Sunitinib (SU) in Combination with Trastuzumab (T) for the Treatment of Advanced Breast Cancer (ABC): Activity and Safety Results from a Phase II Study. Cancer Res 2009. [DOI: 10.1158/0008-5472.sabcs-09-201] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: SU is an oral, multitargeted tyrosine kinase inhibitor of VEGFRs, PDGFRs, KIT, RET, FLT3, and CSF-1R, with single-agent activity in patients (pts) with heavily pretreated ABC (locally recurrent or metastatic breast cancer). T is approved for 2nd-line monotherapy and in combination with taxane-based therapies for 1st-line ABC. The combination of SU + T in HER2+ ABC pts was investigated.Materials and methods: Eligible pts with HER2+ ABC received a starting dose of oral SU 37.5 mg/d (continuous daily dosing [CDD]) and either T administered wkly (iv loading 4 mg/kg then wkly 2 mg/kg) or q3w (loading 8 mg/kg then q3w 6 mg/kg). Due to changing standard of care, the trial was amended to include pts having prior chemotherapy in the 1st-line setting. Previous treatment (tx) with T (± lapatinib) was permitted. The primary endpoint was objective response rate (ORR). Secondary endpoints included safety, progression-free survival (PFS), pharmacokinetics (PK) and quality of life (QoL).Results: As of April 2009, 60 pts were enrolled (6 on the original protocol and 54 under the amendment). Of 54 pts enrolled post-amendment, 6 pts continue on study and 48 have discontinued, 12 due to AEs. Most (n=31; 57%) pts received SU + T as 1st-line tx and 11/31 pts were completely tx-naïve. Pts received a median of 5 cycles (range: 1–16) of SU and 4 cycles (range: 1–15) of T. SU was dose reduced from 37.5 mg/d to 25 mg/d in 39% of pts. All pts were evaluable for safety and 52 pts were evaluable for efficacy. ORR was 34.6% and clinical benefit rate was 48% (2 CR; 16 PR; 7 SD ≥24 wks). Of the 18 responders, 5 pts were completely tx-naïve and 9 pts were 1st-line. Median PFS was 25.3 wks (95% CI, 19.3, 29.1). Most AEs were G1/2. G3 non-hematologic AEs in ≥10% pts were asthenia (17%) and hypertension (11%) and 3 G4 events occurred (LVEF decline, pulmonary embolism, and pancreatitis). Hematologic AEs (G3/4 in ≥10% pts) were neutropenia (22%) and thrombocytopenia (17%). One G5 event (cardiogenic shock) was reported. LVEF decline/LV dysfunction occurred in 21 pts (6 pts had ≥G3 AEs); 18/21 pts (86%) had received prior anthracycline and 12 pts (57%) prior T. There was no significant on-tx change from baseline in the QoL domain. Mean (SD) steady state level for SU was 46.1 (25.9) ng/mL in agreement with prior observations.Conclusions: The combination of SU (37.5 mg/d; CDD schedule) + T (wkly or q3w) showed acceptable tolerability and antitumor activity in HER2+ ABC pts without adversely affecting overall QoL.
Citation Information: Cancer Res 2009;69(24 Suppl):Abstract nr 201.
Collapse
|
1778
|
Aubert B, Karyotakis Y, Lees JP, Poireau V, Prencipe E, Prudent X, Tisserand V, Garra Tico J, Grauges E, Martinelli M, Palano A, Pappagallo M, Eigen G, Stugu B, Sun L, Battaglia M, Brown DN, Hooberman B, Kerth LT, Kolomensky YG, Lynch G, Osipenkov IL, Tackmann K, Tanabe T, Hawkes CM, Soni N, Watson AT, Koch H, Schroeder T, Asgeirsson DJ, Hearty C, Mattison TS, McKenna JA, Barrett M, Khan A, Randle-Conde A, Blinov VE, Bukin AD, Buzykaev AR, Druzhinin VP, Golubev VB, Onuchin AP, Serednyakov SI, Skovpen YI, Solodov EP, Todyshev KY, Bondioli M, Curry S, Eschrich I, Kirkby D, Lankford AJ, Lund P, Mandelkern M, Martin EC, Stoker DP, Atmacan H, Gary JW, Liu F, Long O, Vitug GM, Yasin Z, Sharma V, Campagnari C, Hong TM, Kovalskyi D, Mazur MA, Richman JD, Beck TW, Eisner AM, Heusch CA, Kroseberg J, Lockman WS, Martinez AJ, Schalk T, Schumm BA, Seiden A, Wang L, Winstrom LO, Cheng CH, Doll DA, Echenard B, Fang F, Hitlin DG, Narsky I, Ongmongkolkul P, Piatenko T, Porter FC, Andreassen R, Mancinelli G, Meadows BT, Mishra K, Sokoloff MD, Bloom PC, Ford WT, Gaz A, Hirschauer JF, Nagel M, Nauenberg U, Smith JG, Wagner SR, Ayad R, Toki WH, Feltresi E, Hauke A, Jasper H, Karbach TM, Merkel J, Petzold A, Spaan B, Wacker K, Kobel MJ, Nogowski R, Schubert KR, Schwierz R, Bernard D, Latour E, Verderi M, Clark PJ, Playfer S, Watson JE, Andreotti M, Bettoni D, Bozzi C, Calabrese R, Cecchi A, Cibinetto G, Fioravanti E, Franchini P, Luppi E, Munerato M, Negrini M, Petrella A, Piemontese L, Santoro V, Baldini-Ferroli R, Calcaterra A, de Sangro R, Finocchiaro G, Pacetti S, Patteri P, Peruzzi IM, Piccolo M, Rama M, Zallo A, Contri R, Guido E, Lo Vetere M, Monge MR, Passaggio S, Patrignani C, Robutti E, Tosi S, Morii M, Adametz A, Marks J, Schenk S, Uwer U, Bernlochner FU, Lacker HM, Lueck T, Volk A, Dauncey PD, Tibbetts M, Behera PK, Charles MJ, Mallik U, Cochran J, Crawley HB, Dong L, Eyges V, Meyer WT, Prell S, Rosenberg EI, Rubin AE, Gao YY, Gritsan AV, Guo ZJ, Arnaud N, D'Orazio A, Davier M, Derkach D, Firmino da Costa J, Grosdidier G, Le Diberder F, Lepeltier V, Lutz AM, Malaescu B, Roudeau P, Schune MH, Serrano J, Sordini V, Stocchi A, Wang LL, Wormser G, Lange DJ, Wright DM, Bingham I, Burke JP, Chavez CA, Fry JR, Gabathuler E, Gamet R, Hutchcroft DE, Payne DJ, Touramanis C, Bevan AJ, Clarke CK, Di Lodovico F, Sacco R, Sigamani M, Cowan G, Paramesvaran S, Wren AC, Brown DN, Davis CL, Fritsch M, Gradl W, Hafner A, Alwyn KE, Bailey D, Barlow RJ, Jackson G, Lafferty GD, West TJ, Yi JI, Anderson J, Chen C, Jawahery A, Roberts DA, Simi G, Tuggle JM, Dallapiccola C, Salvati E, Cowan R, Dujmic D, Fisher PH, Henderson SW, Sciolla G, Spitznagel M, Yamamoto RK, Zhao M, Patel PM, Robertson SH, Schram M, Biassoni P, Lazzaro A, Lombardo V, Palombo F, Stracka S, Cremaldi L, Godang R, Kroeger R, Sonnek P, Summers DJ, Zhao HW, Nguyen X, Simard M, Taras P, Nicholson H, De Nardo G, Lista L, Monorchio D, Onorato G, Sciacca C, Raven G, Snoek HL, Jessop CP, Knoepfel KJ, LoSecco JM, Wang WF, Corwin LA, Honscheid K, Kagan H, Kass R, Morris JP, Rahimi AM, Sekula SJ, Blount NL, Brau J, Frey R, Igonkina O, Kolb JA, Lu M, Rahmat R, Sinev NB, Strom D, Strube J, Torrence E, Castelli G, Gagliardi N, Margoni M, Morandin M, Posocco M, Rotondo M, Simonetto F, Stroili R, Voci C, del Amo Sanchez P, Ben-Haim E, Bonneaud GR, Briand H, Chauveau J, Hamon O, Leruste P, Marchiori G, Ocariz J, Perez A, Prendki J, Sitt S, Gladney L, Biasini M, Manoni E, Angelini C, Batignani G, Bettarini S, Calderini G, Carpinelli M, Cervelli A, Forti F, Giorgi MA, Lusiani A, Morganti M, Neri N, Paoloni E, Rizzo G, Walsh JJ, Lopes Pegna D, Lu C, Olsen J, Smith AJS, Telnov AV, Anulli F, Baracchini E, Cavoto G, Faccini R, Ferrarotto F, Ferroni F, Gaspero M, Jackson PD, Li Gioi L, Mazzoni MA, Morganti S, Piredda G, Renga F, Voena C, Ebert M, Hartmann T, Schröder H, Waldi R, Adye T, Franek B, Olaiya EO, Wilson FF, Emery S, Esteve L, Hamel de Monchenault G, Kozanecki W, Vasseur G, Yèche C, Zito M, Allen MT, Aston D, Bard DJ, Bartoldus R, Benitez JF, Cenci R, Coleman JP, Convery MR, Dingfelder JC, Dorfan J, Dubois-Felsmann GP, Dunwoodie W, Field RC, Franco Sevilla M, Fulsom BG, Gabareen AM, Graham MT, Grenier P, Hast C, Innes WR, Kaminski J, Kelsey MH, Kim H, Kim P, Kocian ML, Leith DWGS, Li S, Lindquist B, Luitz S, Luth V, Lynch HL, MacFarlane DB, Marsiske H, Messner R, Muller DR, Neal H, Nelson S, O'Grady CP, Ofte I, Perl M, Ratcliff BN, Roodman A, Salnikov AA, Schindler RH, Schwiening J, Snyder A, Su D, Sullivan MK, Suzuki K, Swain SK, Thompson JM, Va'vra J, Wagner AP, Weaver M, West CA, Wisniewski WJ, Wittgen M, Wright DH, Wulsin HW, Yarritu AK, Young CC, Ziegler V, Chen XR, Liu H, Park W, Purohit MV, White RM, Wilson JR, Bellis M, Burchat PR, Edwards AJ, Miyashita TS, Ahmed S, Alam MS, Ernst JA, Pan B, Saeed MA, Zain SB, Soffer A, Spanier SM, Wogsland BJ, Eckmann R, Ritchie JL, Ruland AM, Schilling CJ, Schwitters RF, Wray BC, Drummond BW, Izen JM, Lou XC, Bianchi F, Gamba D, Pelliccioni M, Bomben M, Bosisio L, Cartaro C, Della Ricca G, Lanceri L, Vitale L, Azzolini V, Lopez-March N, Martinez-Vidal F, Milanes DA, Oyanguren A, Albert J, Banerjee S, Bhuyan B, Choi HHF, Hamano K, King GJ, Kowalewski R, Lewczuk MJ, Nugent IM, Roney JM, Sobie RJ, Gershon TJ, Harrison PF, Ilic J, Latham TE, Mohanty GB, Puccio EMT, Band HR, Chen X, Dasu S, Flood KT, Pan Y, Prepost R, Vuosalo CO, Wu SL. Precise measurement of the e+e- --> pi+pi-(gamma) cross section with the initial state radiation method at BABAR. PHYSICAL REVIEW LETTERS 2009; 103:231801. [PMID: 20366141 DOI: 10.1103/physrevlett.103.231801] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/27/2009] [Indexed: 05/29/2023]
Abstract
A precise measurement of the cross section of the process e(+)e(-) --> pi(+)pi(-)(gamma) from threshold to an energy of 3 GeV is obtained with the initial state radiation (ISR) method using 232 fb(-1) of data collected with the BABAR detector at e(+)e(-) center-of-mass energies near 10.6 GeV. The ISR luminosity is determined from a study of the leptonic process e(+)e(-) --> mu(+)mu(-)gamma(gamma). The leading-order hadronic contribution to the muon magnetic anomaly calculated using the pipi cross section measured from threshold to 1.8 GeV is (514.1 +/- 2.2(stat) +/- 3.1(syst)) x 10(-10).
Collapse
|
1779
|
Wang Y, Zhang W, Lesch MF, Horrey WJ, Chen C, Wu S. Changing drivers' attitudes towards mobile phone use through participative simulation testing and feedback. Inj Prev 2009; 15:384-9. [DOI: 10.1136/ip.2008.021196] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
1780
|
Stolyarov I, Illarioshkin S, Chen C, Hou S, Cowles V, Sweeney M. P2.202 Levodopa pharmacokinetics following administration of novel gastric retentive extended-release formulations compared to a reference extended-release tablet in Parkinson's disease patients. Parkinsonism Relat Disord 2009. [DOI: 10.1016/s1353-8020(09)70553-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
1781
|
Chen C, Li D, Shang C. Nanocrystallization of aluminized surface of carbon steel for enhanced resistances to corrosion and corrosive wear. Electrochim Acta 2009. [DOI: 10.1016/j.electacta.2009.08.016] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
1782
|
Aubert B, Karyotakis Y, Lees JP, Poireau V, Prencipe E, Prudent X, Tisserand V, Garra Tico J, Grauges E, Martinelli M, Palano A, Pappagallo M, Eigen G, Stugu B, Sun L, Battaglia M, Brown DN, Kerth LT, Kolomensky YG, Lynch G, Osipenkov IL, Tackmann K, Tanabe T, Hawkes CM, Soni N, Watson AT, Koch H, Schroeder T, Asgeirsson DJ, Fulsom BG, Hearty C, Mattison TS, McKenna JA, Barrett M, Khan A, Randle-Conde A, Blinov VE, Bukin AD, Buzykaev AR, Druzhinin VP, Golubev VB, Onuchin AP, Serednyakov SI, Skovpen YI, Solodov EP, Todyshev KY, Bondioli M, Curry S, Eschrich I, Kirkby D, Lankford AJ, Lund P, Mandelkern M, Martin EC, Stoker DP, Atmacan H, Gary JW, Liu F, Long O, Vitug GM, Yasin Z, Zhang L, Sharma V, Campagnari C, Hong TM, Kovalskyi D, Mazur MA, Richman JD, Beck TW, Eisner AM, Heusch CA, Kroseberg J, Lockman WS, Martinez AJ, Schalk T, Schumm BA, Seiden A, Wang L, Winstrom LO, Cheng CH, Doll DA, Echenard B, Fang F, Hitlin DG, Narsky I, Piatenko T, Porter FC, Andreassen R, Mancinelli G, Meadows BT, Mishra K, Sokoloff MD, Bloom PC, Ford WT, Gaz A, Hirschauer JF, Nagel M, Nauenberg U, Smith JG, Wagner SR, Ayad R, Toki WH, Wilson RJ, Feltresi E, Hauke A, Jasper H, Karbach TM, Merkel J, Petzold A, Spaan B, Wacker K, Kobel MJ, Nogowski R, Schubert KR, Schwierz R, Volk A, Bernard D, Latour E, Verderi M, Clark PJ, Playfer S, Watson JE, Andreotti M, Bettoni D, Bozzi C, Calabrese R, Cecchi A, Cibinetto G, Fioravanti E, Franchini P, Luppi E, Munerato M, Negrini M, Petrella A, Piemontese L, Santoro V, Baldini-Ferroli R, Calcaterra A, de Sangro R, Finocchiaro G, Pacetti S, Patteri P, Peruzzi IM, Piccolo M, Rama M, Zallo A, Contri R, Guido E, Lo Vetere M, Monge MR, Passaggio S, Patrignani C, Robutti E, Tosi S, Chaisanguanthum KS, Morii M, Adametz A, Marks J, Schenk S, Uwer U, Bernlochner FU, Klose V, Lacker HM, Bard DJ, Dauncey PD, Tibbetts M, Behera PK, Charles MJ, Mallik U, Cochran J, Crawley HB, Dong L, Eyges V, Meyer WT, Prell S, Rosenberg EI, Rubin AE, Gao YY, Gritsan AV, Guo ZJ, Arnaud N, Béquilleux J, D'Orazio A, Davier M, Derkach D, Firmino da Costa J, Grosdidier G, Le Diberder F, Lepeltier V, Lutz AM, Malaescu B, Pruvot S, Roudeau P, Schune MH, Serrano J, Sordini V, Stocchi A, Wormser G, Lange DJ, Wright DM, Bingham I, Burke JP, Chavez CA, Fry JR, Gabathuler E, Gamet R, Hutchcroft DE, Payne DJ, Touramanis C, Bevan AJ, Clarke CK, Di Lodovico F, Sacco R, Sigamani M, Cowan G, Paramesvaran S, Wren AC, Brown DN, Davis CL, Denig AG, Fritsch M, Gradl W, Hafner A, Alwyn KE, Bailey D, Barlow RJ, Jackson G, Lafferty GD, West TJ, Yi JI, Anderson J, Chen C, Jawahery A, Roberts DA, Simi G, Tuggle JM, Dallapiccola C, Salvati E, Saremi S, Cowan R, Dujmic D, Fisher PH, Henderson SW, Sciolla G, Spitznagel M, Yamamoto RK, Zhao M, Patel PM, Robertson SH, Schram M, Lazzaro A, Lombardo V, Palombo F, Stracka S, Bauer JM, Cremaldi L, Godang R, Kroeger R, Sonnek P, Summers DJ, Zhao HW, Simard M, Taras P, Nicholson H, De Nardo G, Lista L, Monorchio D, Onorato G, Sciacca C, Raven G, Snoek HL, Jessop CP, Knoepfel KJ, Losecco JM, Wang WF, Corwin LA, Honscheid K, Kagan H, Kass R, Morris JP, Rahimi AM, Regensburger JJ, Sekula SJ, Wong QK, Blount NL, Brau J, Frey R, Igonkina O, Kolb JA, Lu M, Rahmat R, Sinev NB, Strom D, Strube J, Torrence E, Castelli G, Gagliardi N, Margoni M, Morandin M, Posocco M, Rotondo M, Simonetto F, Stroili R, Voci C, Del Amo Sanchez P, Ben-Haim E, Bonneaud GR, Briand H, Chauveau J, Hamon O, Leruste P, Marchiori G, Ocariz J, Perez A, Prendki J, Sitt S, Gladney L, Biasini M, Manoni E, Angelini C, Batignani G, Bettarini S, Calderini G, Carpinelli M, Cervelli A, Forti F, Giorgi MA, Lusiani A, Morganti M, Neri N, Paoloni E, Rizzo G, Walsh JJ, Lopes Pegna D, Lu C, Olsen J, Smith AJS, Telnov AV, Anulli F, Baracchini E, Cavoto G, Faccini R, Ferrarotto F, Ferroni F, Gaspero M, Jackson PD, Li Gioi L, Mazzoni MA, Morganti S, Piredda G, Renga F, Voena C, Ebert M, Hartmann T, Schröder H, Waldi R, Adye T, Franek B, Olaiya EO, Wilson FF, Emery S, Esteve L, Hamel de Monchenault G, Kozanecki W, Vasseur G, Yèche C, Zito M, Allen MT, Aston D, Bartoldus R, Benitez JF, Cenci R, Coleman JP, Convery MR, Dingfelder JC, Dorfan J, Dubois-Felsmann GP, Dunwoodie W, Field RC, Franco Sevilla M, Gabareen AM, Graham MT, Grenier P, Hast C, Innes WR, Kaminski J, Kelsey MH, Kim H, Kim P, Kocian ML, Leith DWGS, Li S, Lindquist B, Luitz S, Luth V, Lynch HL, Macfarlane DB, Marsiske H, Messner R, Muller DR, Neal H, Nelson S, O'Grady CP, Ofte I, Perl M, Ratcliff BN, Roodman A, Salnikov AA, Schindler RH, Schwiening J, Snyder A, Su D, Sullivan MK, Suzuki K, Swain SK, Thompson JM, Va'vra J, Wagner AP, Weaver M, West CA, Wisniewski WJ, Wittgen M, Wright DH, Wulsin HW, Yarritu AK, Young CC, Ziegler V, Chen XR, Liu H, Park W, Purohit MV, White RM, Wilson JR, Burchat PR, Edwards AJ, Miyashita TS, Ahmed S, Alam MS, Ernst JA, Pan B, Saeed MA, Zain SB, Soffer A, Spanier SM, Wogsland BJ, Eckmann R, Ritchie JL, Ruland AM, Schilling CJ, Schwitters RF, Wray BC, Drummond BW, Izen JM, Lou XC, Bianchi F, Gamba D, Pelliccioni M, Bomben M, Bosisio L, Cartaro C, Della Ricca G, Lanceri L, Vitale L, Azzolini V, Lopez-March N, Martinez-Vidal F, Milanes DA, Oyanguren A, Albert J, Banerjee S, Bhuyan B, Choi HHF, Hamano K, King GJ, Kowalewski R, Lewczuk MJ, Nugent IM, Roney JM, Sobie RJ, Gershon TJ, Harrison PF, Ilic J, Latham TE, Mohanty GB, Puccio EMT, Band HR, Chen X, Dasu S, Flood KT, Pan Y, Prepost R, Vuosalo CO, Wu SL. Measurement of B-->K{*}(892)gamma branching fractions and CP and Isospin asymmetries. PHYSICAL REVIEW LETTERS 2009; 103:211802. [PMID: 20366028 DOI: 10.1103/physrevlett.103.211802] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/12/2009] [Indexed: 05/29/2023]
Abstract
We present an analysis of the decays B{0}-->K{*0}(892)gamma and B{+}-->K{*+}(892)gamma using a sample of about 383 x 10{6} BB[-over ] events collected with the BABAR detector at the PEP-II asymmetric energy B factory. We measure the branching fractions B(B{0}-->K{*0}gamma)=(4.47+/-0.10+/-0.16) x 10{-5} and B(B{+}-->K{*+}gamma)=(4.22+/-0.14+/-0.16) x 10{-5}. We constrain the direct CP asymmetry to be -0.033<A(B-->K{*}gamma)<0.028 and the isospin asymmetry to be 0.017<Delta{0-} < 0.116, where the limits are determined by the 90% confidence interval and include both the statistical and systematic uncertainties.
Collapse
|
1783
|
Aubert B, Bona M, Karyotakis Y, Lees JP, Poireau V, Prencipe E, Prudent X, Tisserand V, Tico JG, Grauges E, Lopez L, Palano A, Pappagallo M, Eigen G, Stugu B, Sun L, Abrams GS, Battaglia M, Brown DN, Cahn RN, Jacobsen RG, Kerth LT, Kolomensky YG, Lynch G, Osipenkov IL, Ronan MT, Tackmann K, Tanabe T, Hawkes CM, Soni N, Watson AT, Koch H, Schroeder T, Walker D, Asgeirsson DJ, Fulsom BG, Hearty C, Mattison TS, McKenna JA, Barrett M, Khan A, Blinov VE, Bukin AD, Buzykaev AR, Druzhinin VP, Golubev VB, Onuchin AP, Serednyakov SI, Skovpen YI, Solodov EP, Todyshev KY, Bondioli M, Curry S, Eschrich I, Kirkby D, Lankford AJ, Lund P, Mandelkern M, Martin EC, Stoker DP, Abachi S, Buchanan C, Gary JW, Liu F, Long O, Shen BC, Vitug GM, Yasin Z, Zhang L, Sharma V, Campagnari C, Hong TM, Kovalskyi D, Mazur MA, Richman JD, Beck TW, Eisner AM, Flacco CJ, Heusch CA, Kroseberg J, Lockman WS, Schalk T, Schumm BA, Seiden A, Wang L, Wilson MG, Winstrom LO, Cheng CH, Doll DA, Echenard B, Fang F, Hitlin DG, Narsky I, Piatenko T, Porter FC, Andreassen R, Mancinelli G, Meadows BT, Mishra K, Sokoloff MD, Bloom PC, Ford WT, Gaz A, Hirschauer JF, Nagel M, Nauenberg U, Smith JG, Ulmer KA, Wagner SR, Ayad R, Soffer A, Toki WH, Wilson RJ, Altenburg DD, Feltresi E, Hauke A, Jasper H, Karbach M, Merkel J, Petzold A, Spaan B, Wacker K, Kobel MJ, Mader WF, Nogowski R, Schubert KR, Schwierz R, Sundermann JE, Volk A, Bernard D, Bonneaud GR, Latour E, Thiebaux C, Verderi M, Clark PJ, Gradl W, Playfer S, Watson JE, Andreotti M, Bettoni D, Bozzi C, Calabrese R, Cecchi A, Cibinetto G, Franchini P, Luppi E, Negrini M, Petrella A, Piemontese L, Santoro V, Baldini-Ferroli R, Calcaterra A, de Sangro R, Finocchiaro G, Pacetti S, Patteri P, Peruzzi IM, Piccolo M, Rama M, Zallo A, Buzzo A, Contri R, Lo Vetere M, Macri MM, Monge MR, Passaggio S, Patrignani C, Robutti E, Santroni A, Tosi S, Chaisanguanthum KS, Morii M, Marks J, Schenk S, Uwer U, Klose V, Lacker HM, Bard DJ, Dauncey PD, Nash JA, Vazquez WP, Tibbetts M, Behera PK, Chai X, Charles MJ, Mallik U, Cochran J, Crawley HB, Dong L, Meyer WT, Prell S, Rosenberg EI, Rubin AE, Gao YY, Gritsan AV, Guo ZJ, Lae CK, Denig AG, Fritsch M, Schott G, Arnaud N, Béquilleux J, D'Orazio A, Davier M, da Costa JF, Grosdidier G, Höcker A, Lepeltier V, Le Diberder F, Lutz AM, Pruvot S, Roudeau P, Schune MH, Serrano J, Sordini V, Stocchi A, Wormser G, Lange DJ, Wright DM, Bingham I, Burke JP, Chavez CA, Fry JR, Gabathuler E, Gamet R, Hutchcroft DE, Payne DJ, Touramanis C, Bevan AJ, Clarke CK, George KA, Di Lodovico F, Sacco R, Sigamani M, Cowan G, Flaecher HU, Hopkins DA, Paramesvaran S, Salvatore F, Wren AC, Brown DN, Davis CL, Alwyn KE, Bailey D, Barlow RJ, Chia YM, Edgar CL, Jackson G, Lafferty GD, West TJ, Yi JI, Anderson J, Chen C, Jawahery A, Roberts DA, Simi G, Tuggle JM, Dallapiccola C, Li X, Salvati E, Saremi S, Cowan R, Dujmic D, Fisher PH, Koeneke K, Sciolla G, Spitznagel M, Taylor F, Yamamoto RK, Zhao M, Patel PM, Robertson SH, Lazzaro A, Lombardo V, Palombo F, Bauer JM, Cremaldi L, Eschenburg V, Godang R, Kroeger R, Sanders DA, Summers DJ, Zhao HW, Simard M, Taras P, Viaud FB, Nicholson H, De Nardo G, Lista L, Monorchio D, Onorato G, Sciacca C, Raven G, Snoek HL, Jessop CP, Knoepfel KJ, LoSecco JM, Wang WF, Benelli G, Corwin LA, Honscheid K, Kagan H, Kass R, Morris JP, Rahimi AM, Regensburger JJ, Sekula SJ, Wong QK, Blount NL, Brau J, Frey R, Igonkina O, Kolb JA, Lu M, Rahmat R, Sinev NB, Strom D, Strube J, Torrence E, Castelli G, Gagliardi N, Margoni M, Morandin M, Posocco M, Rotondo M, Simonetto F, Stroili R, Voci C, Sanchez PDA, Ben-Haim E, Briand H, Calderini G, Chauveau J, David P, Del Buono L, Hamon O, Leruste P, Ocariz J, Perez A, Prendki J, Sitt S, Gladney L, Biasini M, Covarelli R, Manoni E, Angelini C, Batignani G, Bettarini S, Carpinelli M, Cervelli A, Forti F, Giorgi MA, Lusiani A, Marchiori G, Morganti M, Neri N, Paoloni E, Rizzo G, Walsh JJ, Pegna DL, Lu C, Olsen J, Smith AJS, Telnov AV, Anulli F, Baracchini E, Cavoto G, del Re D, Di Marco E, Faccini R, Ferrarotto F, Ferroni F, Gaspero M, Jackson PD, Gioi LL, Mazzoni MA, Morganti S, Piredda G, Polci F, Renga F, Voena C, Ebert M, Hartmann T, Schröder H, Waldi R, Adye T, Franek B, Olaiya EO, Wilson FF, Emery S, Escalier M, Esteve L, Ganzhur SF, de Monchenault GH, Kozanecki W, Vasseur G, Yèche C, Zito M, Chen XR, Liu H, Park W, Purohit MV, White RM, Wilson JR, Allen MT, Aston D, Bartoldus R, Bechtle P, Benitez JF, Cenci R, Coleman JP, Convery MR, Dingfelder JC, Dorfan J, Dubois-Felsmann GP, Dunwoodie W, Field RC, Gabareen AM, Gowdy SJ, Graham MT, Grenier P, Hast C, Innes WR, Kaminski J, Kelsey MH, Kim H, Kim P, Kocian ML, Leith DWGS, Li S, Lindquist B, Luitz S, Luth V, Lynch HL, MacFarlane DB, Marsiske H, Messner R, Muller DR, Neal H, Nelson S, O'Grady CP, Ofte I, Perazzo A, Perl M, Ratcliff BN, Roodman A, Salnikov AA, Schindler RH, Schwiening J, Snyder A, Su D, Sullivan MK, Suzuki K, Swain SK, Thompson JM, Va'vra J, Wagner AP, Weaver M, West CA, Wisniewski WJ, Wittgen M, Wright DH, Wulsin HW, Yarritu AK, Yi K, Young CC, Ziegler V, Burchat PR, Edwards AJ, Majewski SA, Miyashita TS, Petersen BA, Wilden L, Ahmed S, Alam MS, Ernst JA, Pan B, Saeed MA, Zain SB, Spanier SM, Wogsland BJ, Eckmann R, Ritchie JL, Ruland AM, Schilling CJ, Schwitters RF, Drummond BW, Izen JM, Lou XC, Bianchi F, Gamba D, Pelliccioni M, Bomben M, Bosisio L, Cartaro C, Ricca GD, Lanceri L, Vitale L, Azzolini V, Lopez-March N, Martinez-Vidal F, Milanes DA, Oyanguren A, Albert J, Banerjee S, Bhuyan B, Choi HHF, Hamano K, Kowalewski R, Lewczuk MJ, Nugent IM, Roney JM, Sobie RJ, Gershon TJ, Harrison PF, Ilic J, Latham TE, Mohanty GB, Band HR, Chen X, Dasu S, Flood KT, Pan Y, Pierini M, Prepost R, Vuosalo CO, Wu SL. Measurement of D{0}-D[-over]{0} mixing from a time-dependent amplitude analysis of D{0}-->K+pi{-}pi{0} decays. PHYSICAL REVIEW LETTERS 2009; 103:211801. [PMID: 20366027 DOI: 10.1103/physrevlett.103.211801] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/28/2008] [Revised: 06/16/2009] [Indexed: 05/29/2023]
Abstract
We present evidence of D{0}-D[-over ]{0} mixing using a time-dependent amplitude analysis of the decay D{0}-->K+pi{-}pi;{0} in a data sample of 384 fb{-1} collected with the BABAR detector at the PEP-II e+e{-} collider at the Stanford Linear Accelerator Center. Assuming CP conservation, we measure the mixing parameters x{Kpipi{0}}{'}=[2.61{-0.68}{+0.57}(stat)+/-0.39(syst)]%, y{Kpipi;{0}}{'}=[-0.06{-0.64}{+0.55}(stat)+/-0.34(syst)]%. This result is inconsistent with the no-mixing hypothesis with a significance of 3.2 standard deviations. We find no evidence of CP violation in mixing.
Collapse
|
1784
|
Qv J, Chen G, Shen Z, Jiang G, Ding J, Gao W, Chen C. Activation of complement in the discordant heart xenotransplantation of pig-to-monkey model and the impact of intrathymic inoculation of xenogeneic antigen combined with whole-body gamma-radiation. Transplant Proc 2009; 41:3905-8. [PMID: 19917409 DOI: 10.1016/j.transproceed.2009.05.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2008] [Revised: 03/15/2009] [Accepted: 05/20/2009] [Indexed: 10/20/2022]
Abstract
OBJECTIVE This study investigated changes in complement in discordant heart xenotransplantation using a pig-to-monkey model as well as the impact of intrathymic inoculation (IT) with xenogeneic antigen combined with whole-body gamma-radiation (WBI). METHODS In this experiment, pigs and monkeys selected as donors and recipients, respectively, were randomly divided into three groups: a blank group (group A), a whole-body irradiation group (group B) and an irradiation plus intrathymic injection group (group C). In every group, monkeys underwent heterotopic heart xenotransplantation. RESULTS The results showed that the survival of donor hearts in group C was significantly longer than that of group A (P < .01). In mixed lymphocyte reactions, there was a significant reduction of the stimulation index in group C compared with group A. After xenotransplantation, the level of xenoreactive antibody in group C rose slower than that in group A or group B (P < .01). After rejection, the levels of CD46 and C3 declined greatly. CONCLUSIONS These results suggested that pretreatment with IT and WBI induced T-cell immunosuppression, restraining elicited xenoreactive antibody production of both immunoglobulin M and immunoglobulin G classes. However, it did not hinder complement activation via the classical pathway during hyperacute rejection and consequent xenograft rejection.
Collapse
|
1785
|
Chen C, Malek AA, Wargo MJ, Hogan DA, Beattie GA. The ATP-binding cassette transporter Cbc (choline/betaine/carnitine) recruits multiple substrate-binding proteins with strong specificity for distinct quaternary ammonium compounds. Mol Microbiol 2009; 75:29-45. [PMID: 19919675 DOI: 10.1111/j.1365-2958.2009.06962.x] [Citation(s) in RCA: 68] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
We identified a choline, betaine and carnitine transporter, designated Cbc, from Pseudomonas syringae and Pseudomonas aeruginosa that is unusual among members of the ATP-binding cassette (ABC) transporter family in its use of multiple periplasmic substrate-binding proteins (SBPs) that are highly specific for their substrates. The SBP encoded by the cbcXWV operon, CbcX, binds choline with a high affinity (K(m), 2.6 microM) and, although it also binds betaine (K(m), 24.2 microM), CbcXWV-mediated betaine uptake did not occur in the presence of choline. The CbcX orthologue ChoX from Sinorhizobium meliloti was similar to CbcX in these binding properties. The core transporter CbcWV also interacts with the carnitine-specific SBP CaiX (K(m), 24 microM) and the betaine-specific SBP BetX (K(m), 0.6 microM). Unlike most ABC transporter loci, caiX, betX and cbcXWV are separated in the genome. CaiX-mediated carnitine uptake was reduced by CbcX and BetX only when they were bound by their individual ligands, providing the first in vivo evidence for a higher affinity for ligand-bound than ligand-free SBPs by an ABC transporter. These studies demonstrate not only that the Cbc transporter serves as a useful model for exploring ABC transporter component interactions, but also that the orphan SBP genes common to bacterial genomes can encode functional SBPs.
Collapse
|
1786
|
Mah D, Chen C, Milan E, Tsai S, Garg M, Hong L, Yaparpalvi R, Kalnicki S. Potential Dose Escalation to Prostate Cancer using Electromagnetic Transponders: Effect of Margin Reduction on OAR and Treatment Time. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.1306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
1787
|
Zhao C, Xiao W, Han F, Lu L, Huang S, Wu S, Chen C, Chen J, Lin C, Deng X. Long-term Results and Prognostic Factors of Primary Nasopharyngeal Carcinoma Patients Treated with Intensity Modulated-Radiotherapy. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.1441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
1788
|
Chen C, Chai H, Wang X, Lin PH, Yao Q. Corrigendum to: Chlamydia heat shock protein 60 decreases expression of endothelial nitric oxide synthase in human and porcine coronary artery endothelial cells. Cardiovasc Res 2009. [DOI: 10.1093/cvr/cvp316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
1789
|
Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, Doherty JA, Rossing MA, Whittemore AS, McGuire V, DiCioccio RA, Goodman MT, Lurie G, Carney ME, Wilkens LR, Ness RB, Moysich KB, Edwards R, Jennison E, Kjaer SK, Hogdall E, Hogdall CK, Goode EL, Sellers TA, Vierkant RA, Cunningham JM, Schildkraut JM, Berchuck A, Moorman PG, Iversen ES, Cramer DW, Terry KL, Vitonis AF, Titus-Ernstoff L, Song H, Pharoah PDP, Spurdle AB, Anton-Culver H, Ziogas A, Brewster W, Galitovskiy V, Chenevix-Trench G. Erratum: Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium. Br J Cancer 2009. [PMCID: PMC2778538 DOI: 10.1038/sj.bjc.6605431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
1790
|
Adesiyun T, Lee B, Yueh J, Chen C, Colakoglu S, Nguyen M, Recht A. Impact of Sequencing of Postmastectomy Radiotherapy and Breast Reconstruction on Timing and Rate of Complications and Patient Satisfaction. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
1791
|
Rusthoven K, Feigenberg S, Raben D, Kane M, Song J, Nicolaou N, Mehra R, Burtness B, Swing R, Chen C. Initial Results of a Phase I Dose Escalation Trial of Concurrent and Maintenance Erlotinib and Re-irradiation for Recurrent and New Primary Head and Neck Cancer. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.935] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
1792
|
Hannan R, Spierer M, Skinner W, Kabarriti R, Chen C, Bernstein K, Landau E, Miller E, Hong L, Kalnicki S. Hypofractionated Whole Breast Radiation Therapy for Large-breasted Patients. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
1793
|
Raben D, Chen C, Loo B, Graves E, Kavanagh B. Metabolic Tumor Volume and Oropharynx Subsite as Prognostic Factors in Advanced Head and Neck Cancer. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.943] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
1794
|
Kavanagh B, Chen C, Thorburn A, Zhang L, Frederick B, Camidge D. Serum Cell Death Marker Increases after IMRT for Glioblastoma or SBRT for Epithelial Tumors: A Clinical Measure of Apoptosis as Therapeutic Mechanism. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
1795
|
Aubert B, Karyotakis Y, Lees JP, Poireau V, Prencipe E, Prudent X, Tisserand V, Tico JG, Grauges E, Martinelli M, Palano A, Pappagallo M, Eigen G, Stugu B, Sun L, Battaglia M, Brown DN, Kerth LT, Kolomensky YG, Lynch G, Osipenkov IL, Tackmann K, Tanabe T, Hawkes CM, Soni N, Watson AT, Koch H, Schroeder T, Asgeirsson DJ, Fulsom BG, Hearty C, Mattison TS, McKenna JA, Barrett M, Khan A, Randle-Conde A, Blinov VE, Bukin AD, Buzykaev AR, Druzhinin VP, Golubev VB, Onuchin AP, Serednyakov SI, Skovpen YI, Solodov EP, Todyshev KY, Bondioli M, Curry S, Eschrich I, Kirkby D, Lankford AJ, Lund P, Mandelkern M, Martin EC, Stoker DP, Atmacan H, Gary JW, Liu F, Long O, Vitug GM, Yasin Z, Sharma V, Campagnari C, Hong TM, Kovalskyi D, Mazur MA, Richman JD, Beck TW, Eisner AM, Heusch CA, Kroseberg J, Lockman WS, Martinez AJ, Schalk T, Schumm BA, Seiden A, Wang L, Winstrom LO, Cheng CH, Doll DA, Echenard B, Fang F, Hitlin DG, Narsky I, Ongmongkolkul P, Piatenko T, Porter FC, Andreassen R, Mancinelli G, Meadows BT, Mishra K, Sokoloff MD, Bloom PC, Ford WT, Gaz A, Hirschauer JF, Nagel M, Nauenberg U, Smith JG, Wagner SR, Ayad R, Toki WH, Wilson RJ, Feltresi E, Hauke A, Jasper H, Karbach TM, Merkel J, Petzold A, Spaan B, Wacker K, Kobel MJ, Nogowski R, Schubert KR, Schwierz R, Bernard D, Latour E, Verderi M, Clark PJ, Playfer S, Watson JE, Andreotti M, Bettoni D, Bozzi C, Calabrese R, Cecchi A, Cibinetto G, Fioravanti E, Franchini P, Luppi E, Munerato M, Negrini M, Petrella A, Piemontese L, Santoro V, Baldini-Ferroli R, Calcaterra A, de Sangro R, Finocchiaro G, Pacetti S, Patteri P, Peruzzi IM, Piccolo M, Rama M, Zallo A, Contri R, Guido E, Lo Vetere M, Monge MR, Passaggio S, Patrignani C, Robutti E, Tosi S, Chaisanguanthum KS, Morii M, Adametz A, Marks J, Schenk S, Uwer U, Bernlochner FU, Klose V, Lacker HM, Lueck T, Volk A, Bard DJ, Dauncey PD, Tibbetts M, Behera PK, Charles MJ, Mallik U, Cochran J, Crawley HB, Dong L, Eyges V, Meyer WT, Prell S, Rosenberg EI, Rubin AE, Gao YY, Gritsan AV, Guo ZJ, Arnaud N, Béquilleux J, D'Orazio A, Davier M, Derkach D, da Costa JF, Grosdidier G, Le Diberder F, Lepeltier V, Lutz AM, Malaescu B, Pruvot S, Roudeau P, Schune MH, Serrano J, Sordini V, Stocchi A, Wormser G, Lange DJ, Wright DM, Bingham I, Burke JP, Chavez CA, Fry JR, Gabathuler E, Gamet R, Hutchcroft DE, Payne DJ, Touramanis C, Bevan AJ, Clarke CK, Di Lodovico F, Sacco R, Sigamani M, Cowan G, Paramesvaran S, Wren AC, Brown DN, Davis CL, Denig AG, Fritsch M, Gradl W, Hafner A, Alwyn KE, Bailey D, Barlow RJ, Jackson G, Lafferty GD, West TJ, Yi JI, Anderson J, Chen C, Jawahery A, Roberts DA, Simi G, Tuggle JM, Dallapiccola C, Salvati E, Cowan R, Dujmic D, Fisher PH, Henderson SW, Sciolla G, Spitznagel M, Yamamoto RK, Zhao M, Patel PM, Robertson SH, Schram M, Biassoni P, Lazzaro A, Lombardo V, Palombo F, Stracka S, Cremaldi L, Godang R, Kroeger R, Sonnek P, Summers DJ, Zhao HW, Simard M, Taras P, Nicholson H, De Nardo G, Lista L, Monorchio D, Onorato G, Sciacca C, Raven G, Snoek HL, Jessop CP, Knoepfel KJ, Losecco JM, Wang WF, Corwin LA, Honscheid K, Kagan H, Kass R, Morris JP, Rahimi AM, Sekula SJ, Wong QK, Blount NL, Brau J, Frey R, Igonkina O, Kolb JA, Lu M, Rahmat R, Sinev NB, Strom D, Strube J, Torrence E, Castelli G, Gagliardi N, Margoni M, Morandin M, Posocco M, Rotondo M, Simonetto F, Stroili R, Voci C, Del Amo Sanchez P, Ben-Haim E, Bonneaud GR, Briand H, Chauveau J, Hamon O, Leruste P, Marchiori G, Ocariz J, Perez A, Prendki J, Sitt S, Gladney L, Biasini M, Manoni E, Angelini C, Batignani G, Bettarini S, Calderini G, Carpinelli M, Cervelli A, Forti F, Giorgi MA, Lusiani A, Morganti M, Neri N, Paoloni E, Rizzo G, Walsh JJ, Lopes Pegna D, Lu C, Olsen J, Smith AJS, Telnov AV, Anulli F, Baracchini E, Cavoto G, Faccini R, Ferrarotto F, Ferroni F, Gaspero M, Jackson PD, Gioi LL, Mazzoni MA, Morganti S, Piredda G, Renga F, Voena C, Ebert M, Hartmann T, Schröder H, Waldi R, Adye T, Franek B, Olaiya EO, Wilson FF, Emery S, Esteve L, Hamel de Monchenault G, Kozanecki W, Vasseur G, Yèche C, Zito M, Allen MT, Aston D, Bartoldus R, Benitez JF, Cenci R, Coleman JP, Convery MR, Dingfelder JC, Dorfan J, Dubois-Felsmann GP, Dunwoodie W, Field RC, Sevilla MF, Gabareen AM, Graham MT, Grenier P, Hast C, Innes WR, Kaminski J, Kelsey MH, Kim H, Kim P, Kocian ML, Leith DWGS, Li S, Lindquist B, Luitz S, Luth V, Lynch HL, Macfarlane DB, Marsiske H, Messner R, Muller DR, Neal H, Nelson S, O'Grady CP, Ofte I, Perl M, Ratcliff BN, Roodman A, Salnikov AA, Schindler RH, Schwiening J, Snyder A, Su D, Sullivan MK, Suzuki K, Swain SK, Thompson JM, Va'vra J, Wagner AP, Weaver M, West CA, Wisniewski WJ, Wittgen M, Wright DH, Wulsin HW, Yarritu AK, Young CC, Ziegler V, Chen XR, Liu H, Park W, Purohit MV, White RM, Wilson JR, Bellis M, Burchat PR, Edwards AJ, Miyashita TS, Ahmed S, Alam MS, Ernst JA, Pan B, Saeed MA, Zain SB, Soffer A, Spanier SM, Wogsland BJ, Eckmann R, Ritchie JL, Ruland AM, Schilling CJ, Schwitters RF, Wray BC, Drummond BW, Izen JM, Lou XC, Bianchi F, Gamba D, Pelliccioni M, Bomben M, Bosisio L, Cartaro C, Della Ricca G, Lanceri L, Vitale L, Azzolini V, Lopez-March N, Martinez-Vidal F, Milanes DA, Oyanguren A, Albert J, Banerjee S, Bhuyan B, Choi HHF, Hamano K, King GJ, Kowalewski R, Lewczuk MJ, Nugent IM, Roney JM, Sobie RJ, Gershon TJ, Harrison PF, Ilic J, Latham TE, Mohanty GB, Puccio EMT, Band HR, Chen X, Dasu S, Flood KT, Pan Y, Prepost R, Vuosalo CO, Wu SL. Search for a low-mass higgs boson in Upsilon(3S)-->gammaA(0), A(0)-->tau(+)tau(-) at BABAR. PHYSICAL REVIEW LETTERS 2009; 103:181801. [PMID: 19905799 DOI: 10.1103/physrevlett.103.181801] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/15/2009] [Indexed: 05/28/2023]
Abstract
We search for a light Higgs boson A0 in the radiative decay Upsilon(3S)-->gammaA(0), A(0)-->tau+tau-, tau+-->e+nu(e)nu(tau), or tau+-->mu+nu(mu)nu(tau). The data sample contains 122x10(6) Upsilon(3S) events recorded with the BABAR detector. We find no evidence for a narrow structure in the studied tau+tau- invariant mass region of 4.03<m(tau+tau-)<10.10 GeV/c2. We exclude at the 90% confidence level (C.L.) a low-mass Higgs boson decaying to tau+tau- with a product branching fraction B(Upsilon(3S)-->gammaA(0))xB(A(0)-->tau+tau-)>(1.5-16)x10(-5) across the m(tau+tau-) range. We also set a 90% C.L. upper limit on the tau+tau- decay of the eta(b) at B(eta(b)-->tau+tau-)<8%.
Collapse
|
1796
|
Aubert B, Bona M, Karyotakis Y, Lees JP, Poireau V, Prencipe E, Prudent X, Tisserand V, Garra Tico J, Grauges E, Lopez L, Palano A, Pappagallo M, Eigen G, Stugu B, Sun L, Battaglia M, Brown DN, Kerth LT, Kolomensky YG, Lynch G, Osipenkov IL, Tackmann K, Tanabe T, Hawkes CM, Soni N, Watson AT, Koch H, Schroeder T, Asgeirsson DJ, Fulsom BG, Hearty C, Mattison TS, McKenna JA, Barrett M, Khan A, Randle-Conde A, Blinov VE, Bukin AD, Buzykaev AR, Druzhinin VP, Golubev VB, Onuchin AP, Serednyakov SI, Skovpen YI, Solodov EP, Todyshev KY, Bondioli M, Curry S, Eschrich I, Kirkby D, Lankford AJ, Lund P, Mandelkern M, Martin EC, Stoker DP, Abachi S, Buchanan C, Atmacan H, Gary JW, Liu F, Long O, Vitug GM, Yasin Z, Zhang L, Sharma V, Campagnari C, Hong TM, Kovalskyi D, Mazur MA, Richman JD, Beck TW, Eisner AM, Heusch CA, Kroseberg J, Lockman WS, Martinez AJ, Schalk T, Schumm BA, Seiden A, Winstrom LO, Cheng CH, Doll DA, Echenard B, Fang F, Hitlin DG, Narsky I, Piatenko T, Porter FC, Andreassen R, Mancinelli G, Meadows BT, Mishra K, Sokoloff MD, Bloom PC, Ford WT, Gaz A, Hirschauer JF, Nagel M, Nauenberg U, Smith JG, Wagner SR, Ayad R, Soffer A, Toki WH, Wilson RJ, Feltresi E, Hauke A, Jasper H, Karbach M, Merkel J, Petzold A, Spaan B, Wacker K, Kobel MJ, Nogowski R, Schubert KR, Schwierz R, Volk A, Bernard D, Bonneaud GR, Latour E, Verderi M, Clark PJ, Playfer S, Watson JE, Andreotti M, Bettoni D, Bozzi C, Calabrese R, Cecchi A, Cibinetto G, Franchini P, Luppi E, Negrini M, Petrella A, Piemontese L, Santoro V, Baldini-Ferroli R, Calcaterra A, de Sangro R, Finocchiaro G, Pacetti S, Patteri P, Peruzzi IM, Piccolo M, Rama M, Zallo A, Contri R, Lo Vetere M, Monge MR, Passaggio S, Patrignani C, Robutti E, Tosi S, Chaisanguanthum KS, Morii M, Adametz A, Marks J, Schenk S, Uwer U, Bernlochner FU, Klose V, Lacker HM, Bard DJ, Dauncey PD, Tibbetts M, Behera PK, Chai X, Charles MJ, Mallik U, Cochran J, Crawley HB, Dong L, Meyer WT, Prell S, Rosenberg EI, Rubin AE, Gao YY, Gritsan AV, Guo ZJ, Arnaud N, Béquilleux J, D'Orazio A, Davier M, Firmino da Costa J, Grosdidier G, Le Diberder F, Lepeltier V, Lutz AM, Pruvot S, Roudeau P, Schune MH, Serrano J, Sordini V, Stocchi A, Wormser G, Lange DJ, Wright DM, Bingham I, Burke JP, Chavez CA, Fry JR, Gabathuler E, Gamet R, Hutchcroft DE, Payne DJ, Touramanis C, Bevan AJ, Clarke CK, Di Lodovico F, Sacco R, Sigamani M, Cowan G, Paramesvaran S, Wren AC, Brown DN, Davis CL, Denig AG, Fritsch M, Gradl W, Alwyn KE, Bailey D, Barlow RJ, Jackson G, Lafferty GD, West TJ, Yi JI, Anderson J, Chen C, Jawahery A, Roberts DA, Simi G, Tuggle JM, Dallapiccola C, Salvati E, Saremi S, Cowan R, Dujmic D, Fisher PH, Henderson SW, Sciolla G, Spitznagel M, Taylor F, Yamamoto RK, Zhao M, Patel PM, Robertson SH, Lazzaro A, Lombardo V, Palombo F, Bauer JM, Cremaldi L, Godang R, Kroeger R, Summers DJ, Zhao HW, Simard M, Taras P, Nicholson H, De Nardo G, Lista L, Monorchio D, Onorato G, Sciacca C, Raven G, Snoek HL, Jessop CP, Knoepfel KJ, Losecco JM, Wang WF, Corwin LA, Honscheid K, Kagan H, Kass R, Morris JP, Rahimi AM, Regensburger JJ, Sekula SJ, Wong QK, Blount NL, Brau J, Frey R, Igonkina O, Kolb JA, Lu M, Rahmat R, Sinev NB, Strom D, Strube J, Torrence E, Castelli G, Gagliardi N, Margoni M, Morandin M, Posocco M, Rotondo M, Simonetto F, Stroili R, Voci C, Del Amo Sanchez P, Ben-Haim E, Briand H, Chauveau J, Hamon O, Leruste P, Ocariz J, Perez A, Prendki J, Sitt S, Gladney L, Biasini M, Manoni E, Angelini C, Batignani G, Bettarini S, Calderini G, Carpinelli M, Cervelli A, Forti F, Giorgi MA, Lusiani A, Marchiori G, Morganti M, Neri N, Paoloni E, Rizzo G, Walsh JJ, Lopes Pegna D, Lu C, Olsen J, Smith AJS, Telnov AV, Anulli F, Baracchini E, Cavoto G, Faccini R, Ferrarotto F, Ferroni F, Gaspero M, Jackson PD, Li Gioi L, Mazzoni MA, Morganti S, Piredda G, Renga F, Voena C, Ebert M, Hartmann T, Schröder H, Waldi R, Adye T, Franek B, Olaiya EO, Wilson FF, Emery S, Esteve L, Hamel de Monchenault G, Kozanecki W, Vasseur G, Yèche C, Zito M, Chen XR, Liu H, Park W, Purohit MV, White RM, Wilson JR, Allen MT, Aston D, Bartoldus R, Benitez JF, Cenci R, Coleman JP, Convery MR, Dingfelder JC, Dorfan J, Dubois-Felsmann GP, Dunwoodie W, Field RC, Gabareen AM, Graham MT, Grenier P, Hast C, Innes WR, Kaminski J, Kelsey MH, Kim H, Kim P, Kocian ML, Leith DWGS, Li S, Lindquist B, Luitz S, Luth V, Lynch HL, Macfarlane DB, Marsiske H, Messner R, Muller DR, Neal H, Nelson S, O'Grady CP, Ofte I, Perl M, Ratcliff BN, Roodman A, Salnikov AA, Schindler RH, Schwiening J, Snyder A, Su D, Sullivan MK, Suzuki K, Swain SK, Thompson JM, Va'vra J, Wagner AP, Weaver M, West CA, Wisniewski WJ, Wittgen M, Wright DH, Wulsin HW, Yarritu AK, Yi K, Young CC, Ziegler V, Burchat PR, Edwards AJ, Miyashita TS, Ahmed S, Alam MS, Ernst JA, Pan B, Saeed MA, Zain SB, Spanier SM, Wogsland BJ, Eckmann R, Ritchie JL, Ruland AM, Schilling CJ, Schwitters RF, Drummond BW, Izen JM, Lou XC, Bianchi F, Gamba D, Pelliccioni M, Bomben M, Bosisio L, Cartaro C, Della Ricca G, Lanceri L, Vitale L, Azzolini V, Lopez-March N, Martinez-Vidal F, Milanes DA, Oyanguren A, Albert J, Banerjee S, Bhuyan B, Choi HHF, Hamano K, King GJ, Kowalewski R, Lewczuk MJ, Nugent IM, Roney JM, Sobie RJ, Gershon TJ, Harrison PF, Ilic J, Latham TE, Mohanty GB, Puccio EMT, Band HR, Chen X, Dasu S, Flood KT, Pan Y, Prepost R, Vuosalo CO, Wu SL. Evidence for the eta(b)(1S) meson in radiative Upsilon(2S) decay. PHYSICAL REVIEW LETTERS 2009; 103:161801. [PMID: 19905689 DOI: 10.1103/physrevlett.103.161801] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/06/2009] [Indexed: 05/28/2023]
Abstract
We have performed a search for the eta_{b}(1S) meson in the radiative decay of the Upsilon(2S) resonance using a sample of 91.6x10(6) Upsilon(2S) events recorded with the BABAR detector at the PEP-II B factory at the SLAC National Accelerator Laboratory. We observe a peak in the photon energy spectrum at Egamma=609.3(-4.5)(+4.6)(stat)+/-1.9(syst) MeV, corresponding to an eta(b)(1S) mass of 9394.2(-4.9)(+4.8)(stat)+/-2.0(syst) MeV/c2. The branching fraction for the decay Upsilon(2S)-->gamma(eta)b(1S) is determined to be [3.9+/-1.1(stat)-0.9+1.1(syst)]x10(-4). We find the ratio of branching fractions B[Upsilon(2S)-->gamma(eta)b(1S)]/B[Upsilon(3S)-->gamma(eta)b(1S)]=0.82+/-0.24(stat)(-0.19)(+0.20)(syst).
Collapse
|
1797
|
Nasu Y, Kaku H, Kumon H, Na Y, Xie L, Hwang T, Chen C. POD-04.06: An Asia-wide Translational Research on High-Risk Group Detection Based on ms-SNP and IL-12 Immunogene Therapy for Prostate Cancer. Urology 2009. [DOI: 10.1016/j.urology.2009.07.1182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
1798
|
Chen C, Ho D, Chang P. UP-2.022: Pilot Study on the Effect of Composite UmayC in Catheter Associated Lower Urinary Tract Infection. Urology 2009. [DOI: 10.1016/j.urology.2009.07.241] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
1799
|
Jiang ZD, Brosi DM, Chen C, Wilkinson AR. Impairment of perinatal hypoxia-ischemia to the preterm brainstem. J Neurol Sci 2009; 287:172-7. [PMID: 19735922 DOI: 10.1016/j.jns.2009.07.029] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2009] [Accepted: 07/31/2009] [Indexed: 11/17/2022]
Abstract
Hypoxia-ischemia is a major perinatal problem that results in severe damage to the newborn brain. This study assessed functional integrity of the brainstem at term in preterm infants after perinatal hypoxia-ischemia to shed light on the influence of hypoxia-ischemia on the preterm brainstem. We recruited sixty-eight preterm infants after perinatal hypoxia-ischemia, ranging in gestation 28-35 weeks. Brainstem evoked response was studied at term age (37-42 weeks postconceptional age) with 91-910/s clicks using the maximum length sequence technique. Compared with healthy preterm infants, the preterm infants after perinatal hypoxia-ischemia showed a significant increase in I-V interval at very high rates 455 and 910/s of clicks (P<0.05, 0.05). III-V interval and III-V/I-III interval ratio also increased significantly at 455 and 910/s (P<0.05-0.01). The slope of III-V interval-rate function was significantly steeper than in the healthy preterm infants (P<0.05). Compared with normal term controls, the preterm infants after hypoxia-ischemia showed similar, but slightly more significant, abnormalities. The differences between the preterm infants after hypoxia-ischemia and the healthy preterm and term infants generally increased with increasing click rate. These results demonstrated that central components of brainstem auditory evoked response were abnormal at very high click rates in the preterm infants after perinatal hypoxia-ischemia. Click rate-dependent change in the more central part of the brainstem is also abnormal. Apparently, functional integrity of the brainstem, mainly in the more central part, is impaired. Hypoxic-ischemic damage to the preterm brainstem is unlikely to completely recover within a relatively short period after the insult, which is of clinical importance.
Collapse
|
1800
|
Morris P, Chen C, Lin N, Moy B, Come S, Abbruzzi A, Winer E, Norton L, Hudis C, Dang C. 5034 Troponin I and C-reactive protein as biomarkers for changes in left ventricular ejection fraction in patients with early stage breast cancer treated with dose-dense doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel with trastuzumab and lapatinib. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)70926-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|